Pediatr. praxi. 2015;16(5):327-329

Diagnosing and treating chlamydial infections in the paediatrician’s surgery

MUDr.Zarina Karimova
Klinika infekčních, parazitárních a tropických nemocí, Nemocnice Na Bulovce, Praha

The Chlamydiaceae family are cosmopolitan, obligate intracellular pathogens, causing respiratory, urogenital, and ocular infections.

Currently, given their high prevalence, potentially serious complications, and a very difficult interpretation of laboratory results, chlamydial

infections can be considered a major medical problem.

treatment:

Keywords: chlamydia infection, chlamydia, chlamydophila, psittacosis, trachoma, paratrachoma, lymphogranuloma venereum, serology,

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karimova Z. Diagnosing and treating chlamydial infections in the paediatrician’s surgery. Pediatr. praxi. 2015;16(5):327-329.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Stamm WA, Batteiger BE. Introduction to Chlamydia and Chlamydophila. In: Mandel GL, Bennett JE, Dolin R: Principles and practice of infectious diseases, 7th edition. Philadelphia: Churchill Livingstone Elsevier, 2010.
    2. Zákoucká H, Chlamydie v centru pozornosti: Jaké je riziko importu lymphogranuloma venereum. CEM 2009; 1(18): 25-28.
    3. Prográm Epidat, SZÚ.
    4. Galský J, Chlamydie - diagnostika a terapie. Postgraduální medicína 2011; 13(4): 368-377.
    5. Janečková L, Chlamydie - vyšetřovací metody.
    6. Riska PF, Kotlin A, Ajiboye P, et al. Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. Antimicrob Agents Chemother 2004; 48: 3586-3690. Go to original source... Go to PubMed...
    7. Rupp PF, Gebert A, Solbach W, et al. Serine-to-asperagine substitution in the GyrA gene leads to quinolone resistance in moxifloxacin-exposed Chlamydia pneumoniae. Antimicrob Agents Chemother 2005; 49: 406-407. Go to original source... Go to PubMed...
    8. Bébrova E, Beneš J, Čížek J, et al. SKAP. Doporučený postup pro antibiotickou léčbu komunitních respiračních infekcí v primární péči.
    9. Urbáškova P, Marešová V, Jindrák V, et al. SKAP. Konsensus používání antibiotik II. Makrolidová antibiotika.
    10. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy 2010 (40th Edition).
    11. Bartoníčková K, Bébrova L, Beneš J, et al. SKAP. Doporučený postup pro antibiotickou léčbu komunitních infekcí ledvin a močových cest v primární péči.
    12. Golden MR, Whittington WLH, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhoea or chlamydial infection. N Engl J Med 2005; 352: 676-685. Go to original source... Go to PubMed...
    13. Machala L, Chlamydiové infekce. In: Beneš J, et al. Infekční lékařství. Galén, 2009.
    14. Finch RG, Greenwood D, Norrby AR, Whitley RJ. Antibiotics and chemotherapy. Saunders Elsevier, 2010.
    15. Smieja M, Mahoney J, Petrich A, et al. Association of circulating Chlamydia penumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002; 1: 21. Go to original source... Go to PubMed...
    16. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patiens with coronary Artery disease. A meta-analysis of randomized controlled trials. JAMA 2005; 293: 2641-2647. Go to original source... Go to PubMed...
    17. Baker WL, Vouch KA. Azithromycin for secondary prevention of coronary artery disease: A meta-analysis. Am J Health Syst Pharm 2007; 64: 830-836. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.